ArticleBiomarker research2020

Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma.

Liqing Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.